Greece eyes pot of gold as medicinal cannabis licensed Medical Dialogues Bureau20 Nov 2018 9:00 AM ISTATHENS - Greece on Monday issued the first licences to private companies for growing medicinal cannabis in the country, part of an attempt to tap a...
GE Capital sells 1.5 billion dollar healthcare equipment portfolio to TIAA Medical Dialogues Bureau19 Nov 2018 1:47 PM ISTNew Delhi: General Electric Co has recently announced its lending arm has sold a $1.5 billion healthcare equipment finance portfolio to U.S. lender...
Pfizer to raise US drug prices in January after previously backing down under Trump pressure Medical Dialogues Bureau19 Nov 2018 1:14 PM ISTNEW YORK: Pfizer Inc has recently announced that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous...
Aurobindo Pharma to launch oncology, respiratory products in US by 2021 Medical Dialogues Bureau19 Nov 2018 10:23 AM ISTFor the long-term, from 2022 onwards, Aurobindo Pharma plans "launch of inhalers, transdermals, biosimilars, and branded (both Rx and OTC) products in...
Novartis 'completely committed' to Sandoz, has no split-off plan Medical Dialogues Bureau19 Nov 2018 9:40 AM ISTZURICH: Swiss drugmaker Novartis is "completely committed" to its $10 billion-per-year Sandoz generics business, a spokesman said on Thursday after a...
Drug developer Tesaro explores sale Medical Dialogues Bureau19 Nov 2018 9:00 AM ISTNew Delhi: Cancer Drug Developer Tesaro Inc is exploring a sale and is working with financial advisers after receiving takeover interest, Bloomberg...
Ranbaxy beats class certification bid in case over contamination threat Medical Dialogues Bureau18 Nov 2018 12:30 PM ISTNew Delhi: A federal judge has refused to certify a class of consumers who sued India’s Ranbaxy Laboratories Ltd to obtain a refund for generic...
Parnax Lab settles case with SEBI, pays over Rs 10 lakh Medical Dialogues Bureau18 Nov 2018 11:45 AM ISTNew Delhi: Pharmaceutical company Parnax Lab has settled proceedings with markets regulator SEBI in connection with alleged violation of listing norms...
Novartis blood disorder drug Promacta gets FDA approval Medical Dialogues Bureau18 Nov 2018 11:00 AM ISTPromacta has been approved in more than 90 countries as a treatment for low platelet count in patients with chronic immune thrombocytopenic...
Shilpa Medicare gets tentative USFDA nod for Multiple Sclerosis drug Medical Dialogues Bureau18 Nov 2018 10:15 AM ISTNew Delhi: Shilpa Medicare has recently received tentative approval from the US health regulator for Dimethyl Fumarate delayed-release release...
Eli Lilly considers sale of off-patent drug assets in China Medical Dialogues Bureau18 Nov 2018 9:45 AM ISTNew Delhi: Eli Lilly and Co are considering the sale of an off-patent drugs portfolio in China, Bloomberg reported on Friday, citing sources.The...
Pfizer Q2 net profit falls 14% to Rs 95.8 crore Medical Dialogues Bureau18 Nov 2018 9:00 AM ISTNew Delhi: Drug firm Pfizer has recently reported a 13.81 per cent dip in standalone net profit to Rs 95.8 crore for the quarter ended September...
